David H. Persing, EVP, Chief Med/Tech Officer at CEPHEID (CPHD), sold 5,000 shares at $58.60 ($293K) on 2015-02-20, disclosed to the SEC on 2015-02-24.
Seasonal sale ($293k) by EVP, Chief Med/Tech Officer — this insider has traded CPHD in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| CPHD | SELL | 2014-12-01 | $4.1M | — | Filing → |
| CPHD | SELL | 2014-11-17 | $273K | — | Filing → |
| CPHD | SELL | 2014-10-31 | $1.1M | — | Filing → |